Review



retroviral pmscv dcas9 vector  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc retroviral pmscv dcas9 vector
    Retroviral Pmscv Dcas9 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retroviral pmscv dcas9 vector/product/Addgene inc
    Average 93 stars, based on 26 article reviews
    retroviral pmscv dcas9 vector - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    Addgene inc retroviral pmscv dcas9 vector
    Retroviral Pmscv Dcas9 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retroviral pmscv dcas9 vector/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    retroviral pmscv dcas9 vector - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Addgene inc human dcas9 vector
    Drug-like OGA inhibitor KCZ sensitizes MCL cells to BTZ-induced apoptosis. (A) MCL cells were treated with BTZ (6 nM) in the presence of increasing concentrations of KCZ (0–75 μM) for 24 h and analyzed for apoptosis and necrosis by flow cytometry using annexin V and propidium iodide (PI) as probes. Representative dot plots of annexin V (x-axis) and PI (y-axis) are shown. Early and late apoptotic cells are in the lower and upper right quadrants with annexin V positive. NTX, non-treatment. (B) Combination index (CI) analysis by the fixed-ratio model. MCL cells were treated with BTZ and KCZ at the ratio of 1 to 10 and 1 to 5 and CI values were calculated and predicted (trendlines) using CompuSyn software. CI = 1, additivity; CI>1, antagonism; CI<1, synergy. (C) Transcriptional repression of MGEA5 (encoding OGA) was performed using CRISPR interference. (left) Quantitative real-time PCR of MGEA5 mRNA expression and Western blot analysis of OGA protein level in control <t>(dCas9)</t> and OGA-knockdown (dCas9/MGEA5) Jeko-1 and Granta-519 cells. (right) Effect of OGA inhibition on BTZ-induced apoptosis. Cells were treated with BTZ (0–7 nM) for 24 h and apoptosis was determined by Hoechst 33342 assay. Data are mean ± s.d. (n=3). *P < 0.05 vs. BTZ-treated dCas9 control cells; two-sided Student’s t-test. (D) Kaplan-Meier survival curve of patients with DLBCL, segregated according to high (red) or low (green) expression of MGEA5 (encoding OGA), obtained from public database through a bioinformatics analysis using PPISURV (www.bioprofiling.de).
    Human Dcas9 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human dcas9 vector/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    human dcas9 vector - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    Drug-like OGA inhibitor KCZ sensitizes MCL cells to BTZ-induced apoptosis. (A) MCL cells were treated with BTZ (6 nM) in the presence of increasing concentrations of KCZ (0–75 μM) for 24 h and analyzed for apoptosis and necrosis by flow cytometry using annexin V and propidium iodide (PI) as probes. Representative dot plots of annexin V (x-axis) and PI (y-axis) are shown. Early and late apoptotic cells are in the lower and upper right quadrants with annexin V positive. NTX, non-treatment. (B) Combination index (CI) analysis by the fixed-ratio model. MCL cells were treated with BTZ and KCZ at the ratio of 1 to 10 and 1 to 5 and CI values were calculated and predicted (trendlines) using CompuSyn software. CI = 1, additivity; CI>1, antagonism; CI<1, synergy. (C) Transcriptional repression of MGEA5 (encoding OGA) was performed using CRISPR interference. (left) Quantitative real-time PCR of MGEA5 mRNA expression and Western blot analysis of OGA protein level in control (dCas9) and OGA-knockdown (dCas9/MGEA5) Jeko-1 and Granta-519 cells. (right) Effect of OGA inhibition on BTZ-induced apoptosis. Cells were treated with BTZ (0–7 nM) for 24 h and apoptosis was determined by Hoechst 33342 assay. Data are mean ± s.d. (n=3). *P < 0.05 vs. BTZ-treated dCas9 control cells; two-sided Student’s t-test. (D) Kaplan-Meier survival curve of patients with DLBCL, segregated according to high (red) or low (green) expression of MGEA5 (encoding OGA), obtained from public database through a bioinformatics analysis using PPISURV (www.bioprofiling.de).

    Journal: Molecular cancer therapeutics

    Article Title: Inhibition of O -GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid

    doi: 10.1158/1535-7163.MCT-17-0390

    Figure Lengend Snippet: Drug-like OGA inhibitor KCZ sensitizes MCL cells to BTZ-induced apoptosis. (A) MCL cells were treated with BTZ (6 nM) in the presence of increasing concentrations of KCZ (0–75 μM) for 24 h and analyzed for apoptosis and necrosis by flow cytometry using annexin V and propidium iodide (PI) as probes. Representative dot plots of annexin V (x-axis) and PI (y-axis) are shown. Early and late apoptotic cells are in the lower and upper right quadrants with annexin V positive. NTX, non-treatment. (B) Combination index (CI) analysis by the fixed-ratio model. MCL cells were treated with BTZ and KCZ at the ratio of 1 to 10 and 1 to 5 and CI values were calculated and predicted (trendlines) using CompuSyn software. CI = 1, additivity; CI>1, antagonism; CI<1, synergy. (C) Transcriptional repression of MGEA5 (encoding OGA) was performed using CRISPR interference. (left) Quantitative real-time PCR of MGEA5 mRNA expression and Western blot analysis of OGA protein level in control (dCas9) and OGA-knockdown (dCas9/MGEA5) Jeko-1 and Granta-519 cells. (right) Effect of OGA inhibition on BTZ-induced apoptosis. Cells were treated with BTZ (0–7 nM) for 24 h and apoptosis was determined by Hoechst 33342 assay. Data are mean ± s.d. (n=3). *P < 0.05 vs. BTZ-treated dCas9 control cells; two-sided Student’s t-test. (D) Kaplan-Meier survival curve of patients with DLBCL, segregated according to high (red) or low (green) expression of MGEA5 (encoding OGA), obtained from public database through a bioinformatics analysis using PPISURV (www.bioprofiling.de).

    Article Snippet: The constructed sgRNA plasmid was then transfected into Jeko-1 cells stably expressing human dCas9 vector (Addgene, #44246) ( 26 ) by nucleofection using 4D-Nucleofector TM (Lonza, Cologne, Germany) with EW113 device program.

    Techniques: Flow Cytometry, Software, CRISPR, Real-time Polymerase Chain Reaction, Expressing, Western Blot, Control, Knockdown, Inhibition